Major stock indexes sank Wednesday as investors digested the latest batch of bank earnings reports and readings on wholesale inflation and retail sales, while safe-haven gold and silver surged to fresh record highs.
The tech-heavy Nasdaq, benchmark S&P 500, and blue-chip Dow Jones Industrial Average fell a respective 1.5%, 1%, and 0.6% in recent trading.
Major stock indexes closed lower yesterday, with the Dow shedding 400 points, as investors digested a consumer inflation reading that matched expectations and bank earnings season kicked off with a mixed report from JPMorgan Chase (JPM), whose stock declined more than 4%. Shares of the largest U.S. bank were down a further 1% in recent trading.
Bank of America (BAC) and Wells Fargo (WFC) shares pulled back 5% and 5.5%, respectively, after reporting fiscal 2025 fourth-quarter results early Wednesday, while Citigroup (C) stock reversed early gains and fell 4.5%.
Before the bell, the Bureau of Labor Statistics’ delayed Producer Price Index report for November revealed wholesale prices rose 0.2% from September—the last monthly reading before the U.S. government shutdown—while economists were expecting an 0.3% rise. Meanwhile, U.S. retail sales rose 0.6% in November when a 0.4% increase was predicted.
The 10-year Treasury yield, which influences interest rates on a variety of commercial and consumer loans, recently traded around 4.14%, down from Tuesday’s close above 4.18%.
Prices of precious metals surged Wednesday, with gold futures hitting an all-time high of $4,650 an ounce and silver crossing the $90-an-ounce threshold for the first time. Gold was up 0.5% to $4,620 an ounce in recent trading, while silver surged 5% to $90.70 after setting a record of nearly $92.20.
Financial stocks continued their descent after President Donald Trump over the weekend suggested capping credit card interest rates at 10%. Shares of payment processors Visa (V) and Mastercard (MA), among the biggest S&P 500 decliners yesterday, were a further 1% lower Wednesday.
Shares of Nvidia (NVDA) fell more than 2% after the Trump administration approved the exporting of its H200 AI chips to China but said the world’s most valuable public company must meet new security requirements first.
Netflix (NFLX) stock slipped more than 2% following reports that the streaming giant was preparing to make its $72 billion bid for Warner Bros. Discovery’s (WBD) HBO Max streaming service and studios all-cash, instead of a mix of cash and stock. Paramount Skydance (PSKY) has made a hostile all-cash offer of $77.9 billion for all of WBD. Paramount and WBD shares edged lower.
West Texas Intermediate futures, the U.S. crude oil benchmark, rose roughly 1.5% to $62.05 a barrel.
Bitcoin was trading around $97,600, up sharply for a second straight day. Bitcoin-treasury firm Strategy (MSTR) was one of the top-performing stocks in the Nasdaq, with shares up almost 4%.
The U.S. dollar index, which tracks the value of the greenback against a basket of foreign currencies, ticked 0.1% lower to 99.01.
January 14, 2026 12:52 PM EST
Chinese Antitrust Probe Sends This Travel Stock Plummeting—What Investors Need to Know
FROM 30 minutes ago
An investigation by Chinese authorities sent a travel stock tumbling Wednesday.
U.S.-listed shares of Trip.com (TCOM) were down nearly 17% in recent trading after China’s State Administration for Market Regulation said it’s investigating the company over potential monopolistic behavior as a dominant travel player in the region.
Trip.com said in a statement that it will cooperate with the investigation and is operating its business as usual.
Cheng Xin / Getty Images
Chinese regulators have been paying closer attention to the operations of large tech companies in recent years. Last year, regulators in the country found that Nvidia (NVDA) had violated antitrust law with a previous acquisition after announcing an investigation in December 2024.
Last week, Chinese authorities said they would look into Meta Platforms’ (META) acquisition of AI startup Manus announced last month, to ensure it is compliant with Chinese export laws.
With Wednesday’s losses, Trip.com shares are down 14% for the year so far after climbing about 5% in 2025.
January 14, 2026 12:19 PM EST
Bank of America CEO Moynihan Predicts Economic Growth Despite ‘Risks’ in 2026
FROM 1 hr 3 min ago
A second big-bank CEO in as many days is sharing upbeat sentiment about the U.S. economy.
Bank of America’s (BAC) Brian Moynihan on Wednesday said while reporting the bank’s latest quarterly financial results that he expects “further economic growth in the year ahead.”
Chris J. Ratcliffe / Bloomberg via Getty Images
The statement followed comments yesterday from JPMorgan Chase (JPM) chief Jamie Dimon, who referenced a “resilient” economy but also highlighted a set of “hazards,” including inflation and geopolitical risks, that he thought markets were underappreciating.
“With consumers and businesses proving resilient, as well as the regulatory environment and tax and trade policies coming into sharper focus, we expect further economic growth in the year ahead,” Moynihan said in a statement. “While any number of risks continue, we are bullish on the U.S. economy in 2026.”
Read the full article here.
January 14, 2026 11:41 AM EST
Energy Sector Outperforms on Down Day for S&P 500
FROM 1 hr 41 min ago
The S&P 500 is having a rough day thus far. Don’t blame energy stocks.
The S&P 500 Energy Sector was up nearly 2.4%, by far the biggest gainer of the 11 sectors tracked by the benchmark index.
Leading performers in the sector include APA (APA), up about 4.5%; Devon Energy (DVN), up 3.5%; and ConocoPhillips (COP), up 3.5%.
Interestingly, more than half of the sectors (6) are in positive territory Wednesday, but the index overall is down 0.8%.
TradingView
January 14, 2026 10:06 AM EST
Strategy Stock Surges Further Along With Bitcoin
FROM 3 hr 16 min ago
Bitcoin is rising again. So are shares of Strategy.
Strategy (MSTR) was the top-performing stock in the Nasdaq early Wednesday, with shares up more than 6%.
Shares of the Bitcoin-treasury firm had surged 6.6% Tuesday as the price of the largest cryptocurrency jumped. Bitcoin recently was trading around $95,800, up from the day’s low of roughly $94,100.
Strategy shares were trading around $185, well off their all-time high of $457.22 set last July 16, when bitcoin was trading around $120,000.
TradingView
January 14, 2026 09:48 AM EST
AI Could Spell Trouble for Software. These Experts Say to Avoid One Stock In Particular
FROM 3 hr 34 min ago
Software was once the hottest industry on Wall Street. Not so in the AI era.
S&P 500 software stocks lagged the broader index for the second consecutive year in 2025 as companies making the “picks and shovels” of the AI buildout—like semiconductors and memory devices—led the stock market higher. And analysts expect the challenges weighing on software stocks, especially application developers, to persist in 2026.
One example: Oppenheimer on Tuesday downgraded Adobe (ADBE) stock to “Perform” from “Outperform” and withdrew its price target entirely, citing threats from AI that apply to varying degrees across the application software industry. The news pulled Adobe, shares of which have lost more than a fifth of their value over the past 12 months, down more than 5% yesterday, and they ticked a further 0.5% lower soon after the opening bell Wednesday.
ANGELA WEISS / AFP via Getty Images
One of the primary issues Adobe faces, according to Oppenheimer, is the perception that AI is weakening its competitive position. Gen AI “is increasing the velocity of content creation while lowering price and subscriber growth,” wrote analysts led by Brian Schwartz. The company faces new competition from LLM providers like OpenAI and advertising platforms like Meta, which have introduced creative tools that allow people other options for doing what previously required an Adobe license and specialized knowledge.
Read the full article here.
January 14, 2026 08:12 AM EST
TG Therapeutics Stock Surges on Lifted Sales Outlook Following Success of Multiple Sclerosis Drug
FROM 5 hr 10 min ago
TG Therapeutics (TGTX) shares popped 10% in premarket trading Wednesday, a day after the biopharmaceutical firm lifted its full-year revenue projections in a presentation at the 44th Annual J.P Morgan Healthcare Conference.
The New York-based firm now sees fiscal 2025 revenue of $616 million, up from the prior projection of $600 million, and sales of multiple sclerosis treatment Briumvi of $594 million, up from the previous guidance of $585 million. Both figures were above Visible Alpha consensus forecasts.
“Briumvi continued to deliver strong commercial performance in 2025, reinforcing our confidence in the multi-billion dollar opportunity for Briumvi,” CEO Michael Weiss said.
The company also sees 2026 revenue of about $875 million to $900 million, including Briumvi U.S. net product revenue of around $825 million to $850 million. The Briumvi projection was well above the Visible Alpha estimate, while the total revenue figure was in line with expectations.
TG Therapeutics shares entered the day down 6% over the past year.
TradingView
January 14, 2026 06:51 AM EST
Stock Futures Fall Ahead of Flurry of Bank Earnings, PPI Inflation Data
FROM 6 hr 31 min ago
Futures contracts associated with the Dow Jones Industrial Average pointed 0.3% lower.
TradingView
S&P 500 futures were down 0.4%.
TradingView
Nasdaq 100 futures declined 0.6%.
TradingView
